Mink Therapeutics, Inc. · NASDAQ:INKT
Mink Therapeutics, Inc. shareholders
As of Jun 30, 2026, 26 institutions reported holding Mink Therapeutics, Inc., 4.0% of its shares. Largest: Vanguard, DNB Asset Management AS and Longbow Finance SA. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Mink Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| Vanguard | 76,947 | 1.5% | +9,296 | Aug 13, 2026 |
| DNB Asset Management AS | 55,142 | 1.1% | new | Aug 11, 2026 |
| Longbow Finance SA | 16,667 | 0.33% | no change | Jul 29, 2026 |
| Geode Capital | 15,573 | 0.31% | −1,772 | Aug 12, 2026 |
| Citadel | 15,440 | 0.30% | new | Aug 14, 2026 |
| BlackRock | 13,382 | 0.26% | +7,179 | Aug 7, 2026 |
| UBS | 4,885 | 0.10% | −10,317 | Aug 13, 2026 |
| Steward Partners Investment Advisory, LLC | 2,000 | 0.04% | no change | Aug 13, 2026 |
| US Bancorp \de\ | 1,995 | 0.04% | new | Aug 12, 2026 |
| Paladin Partners, LLC | 1,000 | 0.02% | first report | Aug 7, 2026 |